nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings
|
Nicholas, Robin A.J |
|
2002 |
20 |
29-30 |
p. 3569-3575 7 p. |
artikel |
2 |
A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart
|
Heron, Leon G |
|
2002 |
20 |
29-30 |
p. 3472-3476 5 p. |
artikel |
3 |
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K)
|
Watanabe, Izumi |
|
2002 |
20 |
29-30 |
p. 3443-3455 13 p. |
artikel |
4 |
Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration
|
Xing, D |
|
2002 |
20 |
29-30 |
p. 3535-3542 8 p. |
artikel |
5 |
Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media
|
Novotny, Laura A |
|
2002 |
20 |
29-30 |
p. 3590-3597 8 p. |
artikel |
6 |
Dual action ectoparasite vaccine targeting ‘exposed’ and ‘concealed’ antigens
|
Trimnell, Adama R |
|
2002 |
20 |
29-30 |
p. 3560-3568 9 p. |
artikel |
7 |
Editorial Board
|
|
|
2002 |
20 |
29-30 |
p. IFC- 1 p. |
artikel |
8 |
Effect of Pneumovax® II vaccination in high-risk individuals on specific antibody and opsonic capacity against specific and non-specific antigen
|
Huo, Z |
|
2002 |
20 |
29-30 |
p. 3532-3534 3 p. |
artikel |
9 |
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine
|
de Jong, A |
|
2002 |
20 |
29-30 |
p. 3456-3464 9 p. |
artikel |
10 |
Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK
|
Hoshino, Yasutaka |
|
2002 |
20 |
29-30 |
p. 3576-3584 9 p. |
artikel |
11 |
Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides
|
Salvatore, Daniela |
|
2002 |
20 |
29-30 |
p. 3477-3484 8 p. |
artikel |
12 |
Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector
|
McKee, Hayley J |
|
2002 |
20 |
29-30 |
p. 3613-3625 13 p. |
artikel |
13 |
Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India
|
Murhekar, M.V |
|
2002 |
20 |
29-30 |
p. 3431-3435 5 p. |
artikel |
14 |
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
|
Jung, Maria-Christina |
|
2002 |
20 |
29-30 |
p. 3598-3612 15 p. |
artikel |
15 |
Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice
|
Halassy Špoljar, Beata |
|
2002 |
20 |
29-30 |
p. 3543-3550 8 p. |
artikel |
16 |
Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity
|
Cusi, M.G |
|
2002 |
20 |
29-30 |
p. 3436-3442 7 p. |
artikel |
17 |
Investigation into a cluster of infant deaths following immunization: evidence for methanol intoxication
|
Darwish, A |
|
2002 |
20 |
29-30 |
p. 3585-3589 5 p. |
artikel |
18 |
Letter to the Editor
|
Belshe, Robert B |
|
2002 |
20 |
29-30 |
p. 3429-3430 2 p. |
artikel |
19 |
Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen
|
Conlan, J.Wayne |
|
2002 |
20 |
29-30 |
p. 3465-3471 7 p. |
artikel |
20 |
Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines
|
Ho, Mei M |
|
2002 |
20 |
29-30 |
p. 3509-3522 14 p. |
artikel |
21 |
Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines
|
Lingnau, Karen |
|
2002 |
20 |
29-30 |
p. 3498-3508 11 p. |
artikel |
22 |
The difficult quest for data on “vanishing” vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium)
|
Beutels, Ph |
|
2002 |
20 |
29-30 |
p. 3551-3559 9 p. |
artikel |
23 |
Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge
|
Fischer, Laurent |
|
2002 |
20 |
29-30 |
p. 3485-3497 13 p. |
artikel |
24 |
Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model
|
Dargeviciute, Ausra |
|
2002 |
20 |
29-30 |
p. 3523-3531 9 p. |
artikel |